A detailed history of Altus Wealth Group LLC transactions in Pfizer Inc stock. As of the latest transaction made, Altus Wealth Group LLC holds 10,718 shares of PFE stock, worth $298,281. This represents 0.15% of its overall portfolio holdings.

Number of Shares
10,718
Previous 11,557 7.26%
Holding current value
$298,281
Previous $332,000 10.54%
% of portfolio
0.15%
Previous 0.19%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

SELL
$25.89 - $29.73 $21,721 - $24,943
-839 Reduced 7.26%
10,718 $297,000
Q4 2023

Jan 29, 2024

SELL
$26.13 - $33.94 $31,303 - $40,660
-1,198 Reduced 9.39%
11,557 $332,000
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $64 - $75
2 Added 0.02%
12,755 $423,000
Q2 2023

Aug 03, 2023

SELL
$36.12 - $41.79 $25,645 - $29,670
-710 Reduced 5.27%
12,753 $467,000
Q1 2023

May 01, 2023

SELL
$39.39 - $51.28 $512 - $666
-13 Reduced 0.1%
13,463 $549,000
Q4 2022

Jan 18, 2023

SELL
$41.75 - $54.5 $4,133 - $5,395
-99 Reduced 0.73%
13,476 $0
Q2 2022

Aug 10, 2022

BUY
$46.53 - $55.17 $139 - $165
3 Added 0.02%
13,575 $584,000
Q1 2022

May 09, 2022

SELL
$45.75 - $56.69 $366 - $453
-8 Reduced 0.06%
13,572 $703,000
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $206 - $306
5 Added 0.04%
13,580 $802,000
Q3 2021

Nov 08, 2021

SELL
$39.25 - $50.42 $108,801 - $139,764
-2,772 Reduced 16.96%
13,575 $584,000
Q2 2021

Aug 12, 2021

BUY
$35.91 - $40.68 $6,930 - $7,851
193 Added 1.19%
16,347 $640,000
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $120,162 - $135,518
3,588 Added 28.55%
16,154 $645,000
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $420,584 - $534,808
12,566 New
12,566 $463,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $156B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Altus Wealth Group LLC Portfolio

Follow Altus Wealth Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altus Wealth Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Altus Wealth Group LLC with notifications on news.